ERICH3: vesicular association and antidepressant treatment response

Selective serotonin reuptake inhibitors (SSRIs) are standard of care for major depressive disorder (MDD) pharmacotherapy, but only approximately half of these patients remit on SSRI therapy. Our previous genome-wide association study identified a single-nucleotide polymorphism (SNP) signal across th...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Molecular psychiatry Ročník 26; číslo 6; s. 2415 - 2428
Hlavní autoři:	Liu, Duan, Zhuang, Yongxian, Zhang, Lingxin, Gao, Huanyao, Neavin, Drew, Carrillo-Roa, Tania, Wang, Yani, Yu, Jia, Qin, Sisi, Kim, Daniel C, Liu, Erica, Nguyen, Thanh Thanh Le, Biernacka, Joanna M, Kaddurah-Daouk, Rima, Dunlop, Boadie W, Craighead, W Edward, Mayberg, Helen S, Binder, Elisabeth B, Frye, Mark A, Wang, Liewei, Weinshilboum, Richard M
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Nature Publishing Group 01.06.2021
Témata:	Antidepressants Antidepressive Agents - therapeutic use Cell culture Central nervous system Clathrin Clinical trials Culture media Depressive Disorder, Major - drug therapy Depressive Disorder, Major - genetics Drug therapy Gene polymorphism Genome-wide association studies Genome-Wide Association Study Genomes Humans Immunofluorescence Isoforms Lysates Mental depression Patients Serotonin - therapeutic use Serotonin uptake inhibitors Serotonin Uptake Inhibitors - therapeutic use Single-nucleotide polymorphism Systematic review
ISSN:	1359-4184, 1476-5578, 1476-5578
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!